During the past decade, Tampere University Hospital Heart Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tampere University Hospital Heart Center" #1 sponsor was "Tampere University Hospital" with 5 trials, followed by "Kati Järvelä" with 2 trials sponsored, "PulseOn Oy" with 2 trials sponsored, "Central Finland Hospital District" with 1 trials sponsored and "North Karelia Central Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tampere University Hospital Heart Center" #1 collaborator was "Atostek Oy" with 2 trials as a collaborator, "TAYS Sydänkeskus Oy" with 2 trials as a collaborator, "Tampere University of Technology" with 2 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Tampere University Hospital Heart Center" are "Arrhythmias, Cardiac" (3 trials), "Postoperative Pain" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Fibrillation and Flutter" (1 trials). Many other conditions were trialed in "Tampere University Hospital Heart Center" in a lesser frequency.

Most popular intervention types in "Tampere University Hospital Heart Center" are "Device" (6 trials), "Drug" (5 trials), "Procedure" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "7.2% NaCl/hydroxyethylstarch" (1 trials), "Antiarrhythmic drug therapy" (1 trials), "Chest Physiotherapy" (1 trials), "Hypercarbia" (1 trials) and "NaCl 0.9%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tampere University Hospital Heart Center" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tampere University Hospital Heart Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Tampere University Hospital Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tampere University Hospital Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".